#clinical_trials
9 articles
Corporate Finance
Artiva Biotherapeutics faces capital shortfall risk ahead of pivotal NK cell therapy trials
ViaNews Editorial Team (Finance)•
Corporate Finance
Cardiff Oncology faces potential $500M+ valuation hit as pivotal cancer trial data looms
ViaNews Editorial Team (Finance)•
Pharmaceutical Investment Risk
Protara Therapeutics Faces 70% Clinical Trial Failure Risk on TARA-002 Bladder Cancer Drug
ViaNews Editorial Team (Finance)•
Biotech Investment Risk
Anebulo Pharmaceuticals Stakes Survival on Single Cannabis Toxicity Drug
ViaNews Editorial Team (Finance)•
Analysis
Four Immunotherapy Companies Race Toward 2026 Launches as Next-Generation Cancer Treatments Near Market
ViaNews Editorial Team (Finance)•
Analysis
Four Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research Cycle
ViaNews Editorial Team (Finance)•